Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Insulet and Dexcom decide not to pursue a joint development agreement to integrate Dexcom’s continuous glucose monitoring technology with Insulet’s insulin-infusing OmniPod.
Accuray’s fiscal 2nd quarter sales plunge and its losses gape wider, sending share prices down almost 10% today.
Lawmakers deliver a 1-2-punch in launching parallel medical device tax repeal bills in the House of Representatives and then the Senate just a day apart.